Overview

Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
- For the prevention of spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis, norfloxacin 400mg per day is a standard regimen. - Ciprofloxacin 750 mg per week is also known to be effective for prevention of SBP. In addition, ciprofloxacin once weekly administration is more convenient and less costly. - Therefore ciprofloxacin once weekly could be more useful if the the efficacy is comparable to norfloxacin once daily. - This study aims to prove ciprofloxacin once weekly administration is as effective as norfloxacin once daily administration for the prevention of SBP in cirrhotic patients with ascites.
Phase:
Phase 4
Details
Lead Sponsor:
Korea University
Collaborators:
Hanyang University
Kyungpook National University
Kyungpook National University Hospital
Pusan National University
Soon Chun Hyang University
Sungkyunkwan University
Yonsei University
Treatments:
Ciprofloxacin
Norfloxacin